FRANKLYN BOOTHE: Open Payments
NPI 1215433297 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 6 payments from 6 companies in 2025. Trend: 2023 $186 · 2024 $358 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Alkermes, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Luye Pharma (USA) Ltd. | 1 | $22 |
Products named: UZEDY, CAPLYTA, SPRAVATO, ARISTADA, ABILIFY ASIMTUFII, ERZOFRI EXTENDED-RELEASE.
Industry payments across PA — which companies pay providers there.
